MedPath

Blood pressure-lowering effect of oral intake of gamma-aminobutyric acid (GABA) in normotensive and grade I hypertensive people: a systematic review with meta-analysis.

Not Applicable
Conditions
This study will be restricted to all original articles of healthy adults (people not suffering from any diseases). However, we will also include grade I hypertensive people as an exception. We will exclude minors, pregnant women, those planning a pregnancy, and lactating women.
Registration Number
JPRN-UMIN000021178
Lead Sponsor
Kagome Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

We will exclude cross-sectional studies because it will be difficult to interpret causal relationships between exposure and outcome. We will also exclude proceedings and unpublished studies.

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath